|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
81,960,000 |
Market
Cap: |
60.16(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.5246 - $5.01 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 834 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Sutro Biopharma is a clinical stage drug discovery, development and manufacturing company focused on deploying its proprietary integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics initially for cancer and autoimmune disorders. Co.'s two product candidates are wholly owned: STRO-001, an antibody-drug conjugates (ADC) directed against CD74, for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
39,226 |
Total Sell Value |
$0 |
$0 |
$0 |
$186,802 |
Total People Sold |
0 |
0 |
0 |
2 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Albini Edward C |
CFO AND SECRETARY |
|
2025-05-15 |
4 |
D |
$0.88 |
$14,076 |
D/D |
(15,995) |
160,805 |
|
- |
|
Albini Edward C |
CFO AND SECRETARY |
|
2025-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,719 |
176,800 |
|
- |
|
Borgman Anne Elizabeth |
CHIEF MEDICAL OFFICER |
|
2025-05-01 |
4 |
D |
$1.07 |
$26,439 |
D/D |
(24,709) |
97,452 |
|
- |
|
Borgman Anne Elizabeth |
CHIEF MEDICAL OFFICER |
|
2025-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
69,063 |
122,161 |
|
- |
|
Srinivasan Venkatesh |
CHIEF TECH OP OFFICER |
|
2025-05-01 |
4 |
D |
$1.07 |
$957 |
D/D |
(894) |
53,686 |
|
- |
|
Srinivasan Venkatesh |
CHIEF TECH OP OFFICER |
|
2025-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
54,580 |
|
- |
|
Fitzpatrick Linda A |
CHIEF PEOPLE & COMM. OFFICER |
|
2025-05-01 |
4 |
D |
$1.07 |
$14,486 |
D/D |
(13,538) |
119,744 |
|
- |
|
Fitzpatrick Linda A |
CHIEF PEOPLE & COMM. OFFICER |
|
2025-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,849 |
133,282 |
|
- |
|
Srinivasan Venkatesh |
CHIEF TECH OP OFFICER |
|
2025-04-11 |
4 |
D |
$0.60 |
$4,562 |
D/D |
(7,603) |
52,080 |
|
- |
|
Srinivasan Venkatesh |
CHIEF TECH OP OFFICER |
|
2025-04-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,250 |
59,683 |
|
- |
|
Pauling David |
Chief Admin. Ofcr. & GC |
|
2025-04-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
98,758 |
|
35% |
|
Albini Edward C |
CFO AND SECRETARY |
|
2025-03-05 |
4 |
D |
$1.36 |
$4,888 |
D/D |
(3,594) |
132,081 |
|
- |
|
Albini Edward C |
CFO AND SECRETARY |
|
2025-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
135,675 |
|
- |
|
Newell William J |
CEO |
|
2025-03-05 |
4 |
D |
$1.36 |
$9,123 |
D/D |
(6,708) |
292,531 |
|
- |
|
Newell William J |
CEO |
|
2025-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
299,239 |
|
- |
|
Fitzpatrick Linda A |
CHIEF PEOPLE & COMM. OFFICER |
|
2025-03-05 |
4 |
D |
$1.36 |
$4,888 |
D/D |
(3,594) |
95,433 |
|
- |
|
Fitzpatrick Linda A |
CHIEF PEOPLE & COMM. OFFICER |
|
2025-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
99,027 |
|
- |
|
Chung Jane |
PRESIDENT AND COO |
|
2025-03-04 |
4 |
D |
$1.42 |
$3,314 |
D/D |
(2,334) |
98,308 |
|
- |
|
Chung Jane |
PRESIDENT AND COO |
|
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,875 |
100,642 |
|
- |
|
Albini Edward C |
CFO AND SECRETARY |
|
2025-03-04 |
4 |
D |
$1.42 |
$5,322 |
D/D |
(3,748) |
126,925 |
|
- |
|
Albini Edward C |
CFO AND SECRETARY |
|
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,125 |
130,673 |
|
- |
|
Newell William J |
CEO |
|
2025-03-04 |
4 |
D |
$1.42 |
$15,813 |
D/D |
(11,136) |
280,489 |
|
- |
|
Newell William J |
CEO |
|
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,125 |
291,625 |
|
- |
|
Fitzpatrick Linda A |
CHIEF PEOPLE & COMM. OFFICER |
|
2025-03-04 |
4 |
D |
$1.42 |
$5,322 |
D/D |
(3,748) |
90,277 |
|
- |
|
Fitzpatrick Linda A |
CHIEF PEOPLE & COMM. OFFICER |
|
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,125 |
94,025 |
|
- |
|
268 Records found
|
|
Page 1 of 11 |
|
|